Estrogen protects against the development of salt-induced cardiac hypertophy in heterozygous proANP gene-disrupted mice

S Jeson Sangaralingham, M. Yat Tse, Stephen C. Pang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Cardiovascular disease is the leading cause of morbidity and mortality in both men and women, but the incidence for women rises sharply after menopause. This has been mainly attributed in the reduction of the female sex hormone estrogen during menopause, suggesting that estrogen may have cardioprotective effiects, although how estrogen exerts its cardioprotective efects is not fully understood. Moreover, the beneficial effiect of estrogen on end-organ damage such as cardiac hypertrophy (CH) remains unclear. The aim of the present study was to examine the interaction between estrogen and the natriuretic peptide system (NPS) and their possible roles during the development of CH by using the proANP heterozygous atrial natriuretic peptide (ANP + / -) mouse as a model of salt-sensitive CH. Male, female ANP + / - mice, and also ovariectomized (Ovx) female ANP + / - mice treated with oil or estrogen were fed either a normal or high salt (HS) diet. After a 5-week treatment period, marked CH was noted in the male and oil-injected Ovx female ANP + / - mice treated with HS. The cardiac NPS, i.e. ANP, B-type natriuretic peptide, and natriuretic peptide receptor-A, was activated in these ANP + / - mice. Interestingly, the female and estrogen-injected Ovx female ANP + / - mice did not exhibit CH, and the cardiac NPS remained unchanged. Collectively, we provide direct evidence that estrogen has the ability to resist the induction of salt-induced CH in ANP + / - mice. Furthermore, the development of hypertrophy may be activating the cardiac NPS in an attempt to blunt these structural changes.

Original languageEnglish (US)
Pages (from-to)143-152
Number of pages10
JournalJournal of Endocrinology
Volume194
Issue number1
DOIs
StatePublished - Jul 2007
Externally publishedYes

Fingerprint

Atrial Natriuretic Factor
Estrogens
Salts
Cardiomegaly
Natriuretic Peptides
Genes
Menopause
Oils
Brain Natriuretic Peptide
Gonadal Steroid Hormones
Hypertrophy
Cardiovascular Diseases
Diet
Morbidity
Mortality
Incidence

ASJC Scopus subject areas

  • Endocrinology

Cite this

Estrogen protects against the development of salt-induced cardiac hypertophy in heterozygous proANP gene-disrupted mice. / Sangaralingham, S Jeson; Yat Tse, M.; Pang, Stephen C.

In: Journal of Endocrinology, Vol. 194, No. 1, 07.2007, p. 143-152.

Research output: Contribution to journalArticle

@article{25c687cad5854907a9fff6363ac734aa,
title = "Estrogen protects against the development of salt-induced cardiac hypertophy in heterozygous proANP gene-disrupted mice",
abstract = "Cardiovascular disease is the leading cause of morbidity and mortality in both men and women, but the incidence for women rises sharply after menopause. This has been mainly attributed in the reduction of the female sex hormone estrogen during menopause, suggesting that estrogen may have cardioprotective effiects, although how estrogen exerts its cardioprotective efects is not fully understood. Moreover, the beneficial effiect of estrogen on end-organ damage such as cardiac hypertrophy (CH) remains unclear. The aim of the present study was to examine the interaction between estrogen and the natriuretic peptide system (NPS) and their possible roles during the development of CH by using the proANP heterozygous atrial natriuretic peptide (ANP + / -) mouse as a model of salt-sensitive CH. Male, female ANP + / - mice, and also ovariectomized (Ovx) female ANP + / - mice treated with oil or estrogen were fed either a normal or high salt (HS) diet. After a 5-week treatment period, marked CH was noted in the male and oil-injected Ovx female ANP + / - mice treated with HS. The cardiac NPS, i.e. ANP, B-type natriuretic peptide, and natriuretic peptide receptor-A, was activated in these ANP + / - mice. Interestingly, the female and estrogen-injected Ovx female ANP + / - mice did not exhibit CH, and the cardiac NPS remained unchanged. Collectively, we provide direct evidence that estrogen has the ability to resist the induction of salt-induced CH in ANP + / - mice. Furthermore, the development of hypertrophy may be activating the cardiac NPS in an attempt to blunt these structural changes.",
author = "Sangaralingham, {S Jeson} and {Yat Tse}, M. and Pang, {Stephen C.}",
year = "2007",
month = "7",
doi = "10.1677/JOE-07-0130",
language = "English (US)",
volume = "194",
pages = "143--152",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Society for Endocrinology",
number = "1",

}

TY - JOUR

T1 - Estrogen protects against the development of salt-induced cardiac hypertophy in heterozygous proANP gene-disrupted mice

AU - Sangaralingham, S Jeson

AU - Yat Tse, M.

AU - Pang, Stephen C.

PY - 2007/7

Y1 - 2007/7

N2 - Cardiovascular disease is the leading cause of morbidity and mortality in both men and women, but the incidence for women rises sharply after menopause. This has been mainly attributed in the reduction of the female sex hormone estrogen during menopause, suggesting that estrogen may have cardioprotective effiects, although how estrogen exerts its cardioprotective efects is not fully understood. Moreover, the beneficial effiect of estrogen on end-organ damage such as cardiac hypertrophy (CH) remains unclear. The aim of the present study was to examine the interaction between estrogen and the natriuretic peptide system (NPS) and their possible roles during the development of CH by using the proANP heterozygous atrial natriuretic peptide (ANP + / -) mouse as a model of salt-sensitive CH. Male, female ANP + / - mice, and also ovariectomized (Ovx) female ANP + / - mice treated with oil or estrogen were fed either a normal or high salt (HS) diet. After a 5-week treatment period, marked CH was noted in the male and oil-injected Ovx female ANP + / - mice treated with HS. The cardiac NPS, i.e. ANP, B-type natriuretic peptide, and natriuretic peptide receptor-A, was activated in these ANP + / - mice. Interestingly, the female and estrogen-injected Ovx female ANP + / - mice did not exhibit CH, and the cardiac NPS remained unchanged. Collectively, we provide direct evidence that estrogen has the ability to resist the induction of salt-induced CH in ANP + / - mice. Furthermore, the development of hypertrophy may be activating the cardiac NPS in an attempt to blunt these structural changes.

AB - Cardiovascular disease is the leading cause of morbidity and mortality in both men and women, but the incidence for women rises sharply after menopause. This has been mainly attributed in the reduction of the female sex hormone estrogen during menopause, suggesting that estrogen may have cardioprotective effiects, although how estrogen exerts its cardioprotective efects is not fully understood. Moreover, the beneficial effiect of estrogen on end-organ damage such as cardiac hypertrophy (CH) remains unclear. The aim of the present study was to examine the interaction between estrogen and the natriuretic peptide system (NPS) and their possible roles during the development of CH by using the proANP heterozygous atrial natriuretic peptide (ANP + / -) mouse as a model of salt-sensitive CH. Male, female ANP + / - mice, and also ovariectomized (Ovx) female ANP + / - mice treated with oil or estrogen were fed either a normal or high salt (HS) diet. After a 5-week treatment period, marked CH was noted in the male and oil-injected Ovx female ANP + / - mice treated with HS. The cardiac NPS, i.e. ANP, B-type natriuretic peptide, and natriuretic peptide receptor-A, was activated in these ANP + / - mice. Interestingly, the female and estrogen-injected Ovx female ANP + / - mice did not exhibit CH, and the cardiac NPS remained unchanged. Collectively, we provide direct evidence that estrogen has the ability to resist the induction of salt-induced CH in ANP + / - mice. Furthermore, the development of hypertrophy may be activating the cardiac NPS in an attempt to blunt these structural changes.

UR - http://www.scopus.com/inward/record.url?scp=34547479239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547479239&partnerID=8YFLogxK

U2 - 10.1677/JOE-07-0130

DO - 10.1677/JOE-07-0130

M3 - Article

C2 - 17592028

AN - SCOPUS:34547479239

VL - 194

SP - 143

EP - 152

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 1

ER -